Non Small Cell Lung Cancer
Thousands of cancer patients are missing out on personalised treatments each year because they are not being tested to see if they might benefit from them
Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked.
Blood samples could offer an alternative to tumour biopsies in lung cancer patients, according to European researchers.
A new drug – crizotinib (Xalkori) – may be more beneficial than chemotherapy for some lung cancer patients.
Scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells.
Around 1,800 lung cancer patients may be missing out on life-saving surgery each year, according to new statistics from Cancer Research UK.
Scientists have discovered that lung cancers can lie dormant for over 20 years before suddenly turning into an aggressive form of the disease
Cancer Research UK has launched a new trial to see if high doses of aspirin might help avoid hearing loss in patients given the drug cisplatin.
Revolutionary clinical trial aims to advance lung cancer treatment thanks to Cancer Research UK and Pharma partnership
Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer